Chemical Structure (Tizanidine 01)
Tizanidine Hydrochloride Capsule
Product Images NDC 75834-207
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 75834-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Tizanidine 02)
Figure 2 (Tizanidine 03)
Figure 3 (Tizanidine 04)
Principal Display Panel (2 mg Capsule Bottle Label)
This is a medication called Tizanidine Hydrochloride, contained in capsules of 2.28mg, equivalent to 2mg of Tizanidine base. It is recommended to store at room temperature, between 15°C-30°C. The medication should be kept out of reach of children and dispensed in containers with child-resistant closure. Zaralet is a registered trademark of Acorda Therapeutics and the medication is manufactured by Cadila Pharmaceutical Ltd. for Nivagen Pharmaceutical, Inc. For more information, it is recommended to refer to the insert.*
Principal Display Panel (4 mg Capsule Bottle Label)
This is a description of Tizanidine Hydrochloride Capsules. Each capsule contains 4.58 mg of tizanidine hydrochloride, which is equivalent to 4 mg of tizanidine base. It is a prescription medication that should be stored at room temperature between 15° to 30° Celsius. It is recommended to read the package insert for dosing information. The medication should be dispensed in containers with child-resistant closures and kept out of reach of children. The brand name for this medication is Zanaflex® which is a registered trademark of Acorda Therapeutics Inc. The medication is manufactured for Nivagen Pharmaceuticals, Inc. The phone number for the manufacturer is 1-877-877-0687. The manufacturer of the medication is Cadta Pharmaceuticals Ltd. located in Gujarat, India. The expiration date for this medication was March 2019.*
Principal Display Panel (6 mg Capsule Bottle Label)
This is a description of a medication called Tizanidine Hydrochloride Capsules with NDC (National Drug Code) 75834-209-15. The medication is available in a container with 150 capsules. Each capsule contains .87 mg of Tizanidine Hydrochloride, which is equal to 6 mg of Zanaflex base. The storage temperature is recommended at 25°C (77°F) with permitted temperature excursions between 15°C to 30°C (53°F to 86°F). The medication should be kept out of reach of children. The package insert should be referred to for more information. The medication is manufactured by Cadila Pharmaceuticals Ltd in India and is distributed by Nivagen in Sacramento, USA. The medication is a registered trademark of Acorda Therapeutics. The last issuance date of this information is March 2019.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
